NEW YORK, NY / ACCESSWIRE / March 9, 2016 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: CUBA Beverage Co. (OTC: CUBV), Arch Therapeutics Inc. (OTC: ARTH), Wolseley PLC (OTC: WOSYY) and Astellas Pharma Inc. (OTC: ALPMY). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
To access our full PDF Research Packages for free, please visit the links below.
============
Full PDF DOWNLOAD Links
(You may have to copy and paste the links into your browser)
CUBV Research Package: http://www.traders-choice.com/pdf?s=CUBV
ARTH Research Package: http://www.traders-choice.com/pdf?s=ARTH
WOSYY Research Package: http://www.traders-choice.com/pdf?s=WOSYY
ALPMY Research Package: http://www.traders-choice.com/pdf?s=ALPMY
============
Highlights from today's reports include:
On Tuesday, March 8, 2016, NASDAQ Composite ended at 4,648.82, down 1.26%, Dow Jones Industrial Average declined 0.64%, to finish the day at 16,964.10, and the S&P 500 closed at 1,979.26, down 1.12%.
- CUBA Beverage Co.'s stock edged lower by 11.76% to close Tuesday's session at USD 0.0015. The company's shares oscillated between USD 0.0014 and USD 0.0020. The stock recorded a trading volume of 14.07 million shares, which was significantly above its 50-day daily average volume of 1.72 million shares and its 52-week average volume of 0.61 million shares. Over the last three days CUBA Beverage Co.'s shares have advanced 36.36% and in the past one week the stock has moved up 7.14%. However, over the last three months the stock has lost 85.00% and in the past six months the shares have shed 87.40%. Furthermore, the stock is trading below its 50-day moving average of USD 0.01. In addition, the stock of CUBA Beverage Co. is trading towards the lower end of its 52-week average of USD 0.0011 - USD 0.0300.
- The stock of Arch Therapeutics Inc. gained 1.23% to close Tuesday's session at USD 0.21. The shares of the company moved in the range of USD 0.20 and USD 0.21. A trading volume of 0.89 million shares was recorded, which was greater than its 150-day daily average volume of 0.43 million shares and its 52-week average volume of 0.44 million shares. Over the last five days Arch Therapeutics Inc.'s shares have advanced 10.75% and in the past one month the stock has gained a momentum of 7.15%. However, over the last three months the stock has declined 5.94% and in the past six months the shares have registered a loss of 35.63%. Further, the company is trading at a price to earnings ratio of 23.68. Additionally, the stock is trading at a price to book ratio of 25.44. Further, the stock is trading above its 50-day moving average of USD 0.19.
- Wolseley PLC's stock decreased by 2.52% to close Tuesday's session at USD 5.42. The company's shares fluctuated in the range of USD 5.38 and USD 5.43. A total of 0.15 million shares exchanged hands, which was lesser than its 50-day daily average volume of 0.26 million shares and its 52-week average volume of 0.16 million shares. Over the last three days Wolseley PLC's shares have declined by 1.28% while in the past one week the stock has moved up 2.65%. Furthermore, over the last three months the stock has lost 7.03% and in the past six months the shares have shed 17.13%. Wolseley PLC has a current dividend yield of 2.48%. Further, the company is trading at a price to earnings ratio of 31.88, compared to its historical PE ratio of 34.82. Besides, the stock is trading above its 50-day moving average of USD 5.06 but below its 200-day moving average of USD 5.64.
- Astellas Pharma Inc.'s stock slipped by 0.79% to close Tuesday's session at USD 13.82. The share price vacillated between USD 13.78 and USD 13.96. The stock recorded a trading volume of 0.04 million shares, much below its 50-day daily average volume of 8.57 million shares and slightly below its 52-week average volume of 0.06 million shares. Over the last five days Astellas Pharma Inc.'s shares have declined by 4.43% and in the past one month the stock has lost 1.92%. In addition, over the last three months the stock has lost 7.95% and year to date the shares have shed 3.42%. Astellas Pharma Inc. has a current dividend yield of 2.02% and a beta of 0.64. The stock is trading at a price to book ratio of 2.54, compared to its historical PB ratio of 3.27. Additionally, the stock is trading at a price to cash flow ratio of 15.02 and a price to sales ratio of 2.56.
About Trader's Choice:
Trader's Choice ("TC") produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. TC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
TC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer"). The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer (collectively referred to as the "Production Team") in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein. The information in this release has been sourced from a third party data base.
NO WARRANTY
TC, the Author and the Reviewer (collectively referred to as the "Publishers") are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.traders-choice.com/.
RESTRICTIONS
TC is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia.
CONTACT
For any questions, inquiries, or comments reach out to us directly at:
E-mail: press (at) traders-choice.com
SOURCE: Trader's Choice
